Ketamine's Wild Ride - From Horse Tranquilizer to Hope Dispenser
2025-06-17
Dr. Ben Synth traces ketamine's remarkable 60+ year journey from its 1962 discovery as a battlefield anesthetic to its 2025 FDA approval as a breakthrough depression treatment. This episode explores how a substance once dismissed as a "party drug" became one of the most significant psychiatric innovations of the 21st century, examining the science behind its rapid-acting antidepressant effects and the clinical trials that proved its effectiveness for treatment-resistant depression.
Click here to browse handpicked Amazon finds inspired by this podcast series!
https://amzn.to/4iKfAMs
Ketamine Therapy: Explained
Quiet.Please- Número de episodios
- 3
- Último episodio
- 2025-06-17
¿Donde puedes escuchar?
Apple Podcasts
Spotify
Podtail
Google Podcasts
RSS
Ketamine therapy has emerged as a groundbreaking treatment for severe mental health conditions, such as treatment-resistant depression, PTSD, and suicidal ideation. Originally developed as an anesthetic in the 1960s, ketamine's rebranding into a medical intervention has been driven by decades of research demonstrating its rapid-acting and transformative effects. With the recent FDA approval of Johnson & Johnson's ketamine-based nasal spray, Spravato, the therapy has gained mainstream acceptance, offering hope to those who have not found relief with traditional treatments. Despite challenges related to accessibility, cost, and long-term safety, ketamine therapy continues to revolutionize mental health care. The article explores its historical development, current applications, and future potential, while addressing societal, ethical, and cultural implications of this innovative treatment.
Click here to browse handpicked Amazon finds inspired by this podcast series!
https://amzn.to/4iKfAMs
www.quietplease.ai